Dr. Robert Vigersky from the U.S. said that only 40%-60% automation was possible for modulating insulin delivery earlier. Now we have reached a stage where even 76%-80% automation is executed successfully, he added.
Diabetes care sector yet to tap benefits of tech advancements, say experts
